Nociceptin immunoreactivity and receptor mRNA in the human trigeminal ganglion

Brain Research

Volumn 964, Issue 2, 2003, Pages 179-186

  Hou, Mingyan ^a   Uddman, Rolf ^a   Tajti, Janos ^a,b   Edvinsson, Lars ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Human trigeminal ganglia; Immunocytochemistry; In vitro pharmacology; Nociceptin; Reverse transcriptase polymerase chain reaction

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; MESSENGER RNA; NITRIC OXIDE SYNTHASE; NOCICEPTIN; NOCICEPTIN RECEPTOR; POTASSIUM; PROTEIN ANTIBODY; SUBSTANCE P; THROMBOXANE A2 RECEPTOR STIMULATING AGENT; U 466166;

ADULT; AGED; ARTICLE; BASILAR ARTERY; BRAIN BLOOD VESSEL; CELL INCLUSION; CELL SIZE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; MALE; NERVE CELL; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RECEPTOR DENSITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIGEMINUS GANGLION; VASOCONSTRICTION; VASODILATATION; VASOMOTOR REFLEX;

AGED; AGED, 80 AND OVER; AUTOPSY; BIOLOGICAL MARKERS; CALCITONIN GENE-RELATED PEPTIDE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEUROPEPTIDES; NITRIC OXIDE SYNTHASE; OPIOID PEPTIDES; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, OPIOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBSTANCE P; TRIGEMINAL GANGLION;

EID: 12244274968     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03927-6     Document Type: Article

References (32)

1. Andoh T., Itoh M., Kuraishi Y. Nociceptin gene expression in rat dorsal root ganglia induced by peripheral inflammation. Neuroreport. 8:1997;2793-2796.
2. Anton B., Fein J., To T., Li X., Silberstein L., Evans C.J. Immunohistochemical localization of ORL-1 in the central nervous system of the rat. J. Comp. Neurol. 368:1996;229-251.
3. Calo G., Guerrini R., Rizzi A., Salvadori S., Regoli D. Pharmacology of nociceptin and its receptor: a novel therapeutic target. Br. J. Pharmacol. 129:2000;1261-1283.
4. Champion H.C., Pierce R.L., Kadowitz P.J. Nociceptin, a novel endogenous ligand for the ORL1 receptor, dilates isolated resistance arteries from the rat. Regul. Pept. 78:1998;69-74.
5. Darland T., Heinricher M.M., Grandy D.K. Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more. Trends Neurosci. 21:1998;215-221.
6. Dun N.J., Miyazaki T., Tang H., Dun E.C. Pituitary adenylate cyclase activating polypeptide immunoreactivity in the rat spinal cord and medulla: implication of sensory and autonomic functions. Neuroscience. 73:1996;677-686.
7. Giuliani S., Lecci A., Maggi C.A. Nociceptin and neurotransmitter release in the periphery. Peptides. 21:2000;977-984.
8. Goadsby P.J., Edvinsson L. Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain. 117:1994;427-434.
9. Goadsby P.J., Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in human and cats. Ann. Neurol. 33:1993;48-56.
10. Gumusel B., Hao Q., Hyman A., Chang J.K., Kapusta D.R., Lippton H. Nociceptin: an endogenous agonist for central opioid like 1 (ORL 1) receptors possesses systemic vasorelaxant properties. Life Sci. 60:1997;141-145.
11. Helyes Z., Nemeth J., Pinter E., Szolcsanyi J. Inhibition by nociceptin of neurogenic inflammation and the release of SP and CGRP from sensory nerve terminals. Br. J. Pharmacol. 121:1997;613-615.
12. Henderson G., McKnight A. The orphan opioid receptor and its endogenous ligand - nociceptin/orphanin FQ. Trends Pharmacol. Sci. 18:1997;293-300.
13. Ikeda K., Watanabe M., Ichikawa T., Kobayashi T., Yano R., Kumanishi T. Distribution of prepro-nociceptin/orphanin FQ mRNA and its receptor mRNA in developing and adult mouse central nervous systems. J. Comp. Neurol. 399:1998;139-151.
14. Inoue M., Kobayashi M., Kozaki S., Zimmer A., Ueda H. Nociceptin/orphanin FQ-induced nociceptive responses through substance P release from peripheral nerve ending in mice. Proc. Natl. Acad. Sci. USA. 95:1998;10949-10953.
15. Marfurt C.F., Del Toro D.R. Corneal sensory pathway in the rat: a horseradish peroxidase tracing study. J. Comp. Neurol. 261:1987;450-459.
16. Mawe G.M., Ellis L.M. Chemical coding of intrinsic and extrinsic nerves in the guinea pig gallbladder: distributions of PACAP and orphanin FQ. Anat. Rec. 262:2001;101-109.
17. Meunier J., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J., Guillemot J., Ferrara P., Monsarrat B., Mazarguil H., Vassart G., Parmentier M., Costentin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 377:1995;532-535.
18. Meunier J.-C. Nociceptin/orphanin FQ and the opioid receptor-like ORL 1 receptor. Eur. J. Pharmacol. 340:1997;1-15.
19. Moller K., Zhang Y.Z., Håkanson R., Luts A., Sjölund B., Uddman R., Sundler F. Pituitary adenylate cyclase activating peptide is a sensory neuropeptide: immunocytochemical and immunochemical evidence. Neuroscience. 57:1993;725-732.
20. Mollereau C., Parmentier M., Mailleux P., Butour J., Moisand C., Chalon P., Caput D., Vassart G., Meunier J. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett. 341:1994;33-38.
21. Mulder H., Uddman R., Moller K., Zhang Y.Z., Ekblad E., Alumets J., Sundler F. Pituitary adenylate cyclase activating polypeptide expression in sensory neurons. Neuroscience. 63:1994;307-312.
22. O'Donnell A.M., Ellis L.M., Riedl M.S., Elde R.P., Mawe G.M. Distribution and chemical coding of orphanin FQ/nociceptin-immunoreactive neurons in the myenteric plexus of guinea pig intestines and sphincter of oddi. J. Comp. Neurol. 430:2001;1-11.
23. Olson G., Olson R., Kastin A. Endogenous opiates: 1994. Peptides. 16:1995;1517-1555.
24. Pan Z.Z., Hirakawa N., Fields H.L. A cellular mechanism for the bidirectional pain-modulating actions of orphanin FQ/nociceptin. Neuron. 26:2000;515-522.
25. Reinscheid R., Nothacker H., Bourson A., Ardati A., Henningsen R., Bunzow J., Grandy D., Langen H., Monsma F.J., Civelli O. Orphanin FQ: a neuropeptide that activates an opioid like G protein-coupled receptor. Science. 270:1995;792-794.
26. Riedl M., Shuster S., Vulchanova L., Wang J., Loh H.H., Elde R. Orphanin FQ/nociceptin-immunoreactive nerve fibers parallel those containing endogenous opioids in rat spinal cord. Neuroreport. 7:1996;1369-1372.
27. Sakurada C., Sakurada S., Katsuyama S., Sasaki J., Tan-No K., Sakurada T. Involvement of tachykinin NK1 receptors in nociceptin-induced hyperalgesia in mice. Brain Res. 841:1999;85-92.
28. Tajti J., Uddman R., Möller S., Sundler F., Edvinsson L. Messenger molecules and receptor mRNA in the human trigeminal ganglion. J. Auton. Nerv. Syst. 76:1999;176-183.
29. Taylor F., Dickenson A. Nociceptin/orphanin FQ. A new opioid, a new analgesic? Neuroreport. 9:1998;R65-70.
30. Williams M., Kowaluk E.A., Arneric S.P. Emerging molecular approaches to pain therapy. J. Med. Chem. 42:1999;1481-1500.
31. Vizzard M.A., Erdman S.L., de Groat W.C. Increased expression of neuronal nitric oxide synthase (NOS) in visceral neurons after nerve injury. J. Neurosci. 15:1995;4033-4045.
32. Xu X.-J., Grass S., Hao J.-X., Xu I.S., Wiesenfeld-Hallin Z. Nociceptin/orphanin FQ in spinal nociceptive mechanisms under normal and pathological conditions. Peptides. 21:2000;1031-1036.